MD.MX

Pediatrix Medical Group, Inc.
MexicoMXNEQUITY DELAYED
Last price
447.00
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
447.00
Day high
447.00
Day low
447.00
Volume
Market cap
P/E (TTM)
52W range
288.00 – 447.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+38.39% +39.4%
1M
+38.39% +34.9%
3M
+38.39% +35.8%
6M
+38.39% +26.3%
YTD
+38.39% +26.2%
1Y
+55.21% +34.9%
3Y
+63.74% -11.6%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on MD.MX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $1.91B$2.01B$1.99B$1.97B -4.9%
Operating revenue $1.90B$2.01B$1.99B$1.95B -5.4%
Cost of revenue $1.42B$1.56B$1.57B$1.50B -8.9%
Gross profit $493.70M$454.34M$421.56M$467.03M +8.7%
Selling, general & admin $240.79M$238.44M$227.54M$231.40M +1.0%
Total operating expense $262.62M$270.66M$263.71M$267.03M -3.0%
Operating income $231.09M$183.68M$157.85M$200.00M +25.8%
Net interest income -$35.97M-$40.74M-$42.08M-$39.70M +11.7%
Pre-tax income $216.43M-$101.34M-$48.36M$81.37M +313.6%
Tax provision $51.04M-$2.27M$12.05M$18.81M +2,346.7%
Net income $165.39M-$99.07M-$60.41M$66.33M +266.9%
Net income to common $165.39M-$99.07M-$60.41M$66.33M +266.9%
Basic EPS 1.97-1.15-0.720.80 +270.7%
Diluted EPS 1.94-1.19-0.730.79 +263.0%
EBIT $252.40M-$60.60M-$6.28M$121.06M +516.5%
EBITDA $274.22M-$28.37M$29.89M$156.70M +1,066.5%
Basic shares 84.08M85.87M84.02M82.95M -2.1%
Diluted shares 85.27M85.87M84.02M84.12M -0.7%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
372.60
+19.97% from price
SMA 20
347.80
+28.52% from price
SMA 50
332.92
+34.27% from price
SMA 100
327.96
+36.30% from price
SMA 200
325.48
+37.34% from price
EMA 12
383.43
+16.58% from price
EMA 26
355.86
+25.61% from price
EMA 50
341.33
+30.96% from price
RSI (14)
100.0
Overbought
MACD (12,26,9)
27.58
Hist 15.08
ATR (14)
8.86
1.98% of price
Realised vol 30D
92.6%
Annualised
Bollinger upper
447.00
20, 2σ
Bollinger lower
248.60
20, 2σ
50 / 200 cross
Golden
332.92 vs 325.48
Trend bias
Above 200
+37.34%

Options chain

Account required
Expiry
Spot 447.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.05
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
92.6%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
0.0%
Peak to trough
Max drawdown 5Y
-70.8%
Peak to trough
ATR 14
8.86
1.98% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.